pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jun 11·1 min read
save

AMA and lawmakers challenge insurer AI denial practices, call for oversight

Jun 11, 2026·read at STAT ↗RegulatoryNeutral

The American Medical Association and several members of Congress are publicly opposing recent denials of care that rely on artificial‑intelligence algorithms used by insurers.

The Department of Health and Human Services’ Office of Inspector General has begun reviewing these AI‑driven denial practices, signaling heightened regulatory scrutiny.

Lawmakers are proposing legislation or hearings to ensure transparency and fairness in AI decision‑making, arguing that patients should not be denied treatment based on opaque algorithms.

The article also notes that mental‑health platform Talkspace has introduced a new chatbot service, reflecting broader interest in AI tools despite the controversy.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: AMA and lawmakers push back on AI care denials”

read at STAT ↗
442 words · retrieved Jun 11
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
Psychiatry & CNS2HematologyType 2 Diabetes

related stories

  • Jul 28After PCOS became PMOS, there’s hope for new awareness among Black and Latina womenSTAT
  • Jul 18Opinion: STAT readers on the value of primary care, obesity as a disease, and moreSTAT
  • Jul 1412 ideas for tackling the U.S. alcohol epidemicSTAT
  • Jul 8Another big premium hike on the horizonSTAT
  • Jul 8Are glucose monitors a good thing for 2-year-olds? Experts look at risks, benefitsSTAT